Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Intangibles (2019 - 2025)

Historic Intangibles for X4 Pharmaceuticals (XFOR) over the last 3 years, with Q3 2025 value amounting to $9.4 million.

  • X4 Pharmaceuticals' Intangibles fell 747.06% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year decrease of 747.06%. This contributed to the annual value of $10.0 million for FY2024, which is N/A changed from last year.
  • Per X4 Pharmaceuticals' latest filing, its Intangibles stood at $9.4 million for Q3 2025, which was down 747.06% from $9.6 million recorded in Q2 2025.
  • X4 Pharmaceuticals' 5-year Intangibles high stood at $10.4 million for Q2 2024, and its period low was $9.4 million during Q3 2025.